BioInfra Life Science Inc. Logo

BioInfra Life Science Inc.

Biotech specializing in oncology diagnostics and R&D for cancer gene treatments.

266470 | KO

Overview

Corporate Details

ISIN(s):
KR7266470004
LEI:
Country:
South Korea
Address:
서울특별시 금천구 가산로9길 66 제1동 712호(가산동, 더리즌밸리지식산업센터), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioInfra Life Science Inc. is a global healthcare and biotechnology company specializing in oncology. The company focuses on cancer prevention and early detection through its proprietary Multi-Biomarker Blood Test, a technology developed over more than 15 years of research that analyzes a small blood sample to assess the risk for eight major cancers. In addition to diagnostics based on protein chip technology, BioInfra is engaged in the research and development of cancer gene treatments, localized drug delivery systems, and technologies to monitor metastasis and recurrence. Established in 2001, the company aims to improve cancer survival rates through innovative healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.7 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.4 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.6 KB
2025-03-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.5 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 10.3 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 908.7 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 91.1 KB
2025-02-28 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 14.7 KB
2024-12-20 00:00
Regulatory News Service
불성실공시법인지정 (공시불이행)
Korean 4.7 KB
2024-12-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 52.7 KB
2024-12-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-12 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 52.6 KB
2024-12-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-06 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.1 KB

Automate Your Workflow. Get a real-time feed of all BioInfra Life Science Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioInfra Life Science Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioInfra Life Science Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom
AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America
AVBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.